Rachel Mumby, Author at Kluwer Patent Blog

(Indirect) infringement, Pharma, Procedure, Revocation, Second Medical Use, Sufficiency of disclosure, United Kingdom, Validity

Pain and Plausibility – the UK Lyrica appeal

Brian Cordery, Rachel Mumby, Steven Willis (Bristows)/October 13, 2016October 31, 2017

Media attention at the English High Court today may have been focussed on the Article 50 challenge but for many patent lawyers operating in the life sciences sector, of equal or greater importance was the handing down of the long-awaited judgment in the Lyrica appeal. To recap briefly, Pfizer was the owner of a patent…

United Kingdom

If it were done when ‘tis done, then ‘twere well it were done quickly

Brian Cordery, Rachel Mumby (Bristows)/July 28, 2014November 1, 2017

We reported recently that the IPCom Guidelines which set out when the English Court should stay patent actions pending EPO oppositions appear to be “More honour’d in the breach than the observance”. This had been in response to the decision of Arnold J of 10 July 2014 who had refused to grant such a stay…

United Kingdom

A (not so) Wii decision from the English High Court

Brian Cordery, Rachel Mumby (Bristows)/July 9, 2014November 1, 2017

Computer games enthusiasts will be interested in this decision from the English High Court in which it was found that the Nintendo Wii and Wii U systems infringe two patents owned by Philips. And for those with World Cup Football fever… one of Philips’ experts had previously done research which showed that in Geoff Hurst’s…